Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Sharp

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Perinatology : Official Journal of the California Perinatal Association|December 6, 2023
Childhood outcomes after maternal antenatal sildenafil treatment for severe early-onset fetal growth restriction: a randomized trial (STRIDER NZAus)Christopher J D McKinlay, Chad Anderson, Jeanie L Y Cheong, et al.
BMJ Open|February 7, 2021
Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trialJacqueline F Gould, Maria Makrides, Thomas R Sullivan, et al.
The New England Journal of Medicine|October 27, 2022
Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 YearsJacqueline F Gould, Maria Makrides, Robert A Gibson, et al.
JAMA Network Open|June 9, 2023
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born PretermThomas R Sullivan, Jacqueline F Gould, Jana M Bednarz, et al.
The Journal of Pediatrics|June 28, 2025
Implementation Fidelity of a Smartphone Application for Population-Based General Movement Assessment: The Early Moves StudyCaroline F Alexander, Sarah E Hall, Alison Salt, et al.
BMJ Open|April 10, 2021
Early Moves: a protocol for a population-based prospective cohort study to establish general movements as an early biomarker of cognitive impairment in infantsCatherine Elliott, Caroline Alexander, Alison Salt, et al.
BMJ Open|May 6, 2021
Protocol for assessing if behavioural functioning of infants born <29 weeks' gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trialJacqueline F Gould, Rachel M Roberts, Peter J Anderson, et al.
JAMA Pediatrics|November 20, 2023
High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical TrialJacqueline F Gould, Rachel M Roberts, Peter J Anderson, et al.
Pediatric Research|June 5, 2026
Blood fatty acid changes in preterm infants in a trial of enteral DHA supplementationRobert A Gibson, Maria Makrides, Jana M Bednarz, et al.
The American Journal of Clinical Nutrition|August 3, 2025
ω-3 and ω-6 fatty acid status within a week of birth in a cross-sectional study of very preterm infantsRobert A Gibson, Jana M Bednarz, Thomas R Sullivan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Perinatology : Official Journal of the California Perinatal Association|December 6, 2023
Childhood outcomes after maternal antenatal sildenafil treatment for severe early-onset fetal growth restriction: a randomized trial (STRIDER NZAus)Christopher J D McKinlay, Chad Anderson, Jeanie L Y Cheong, et al.
BMJ Open|February 7, 2021
Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trialJacqueline F Gould, Maria Makrides, Thomas R Sullivan, et al.
The New England Journal of Medicine|October 27, 2022
Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 YearsJacqueline F Gould, Maria Makrides, Robert A Gibson, et al.
JAMA Network Open|June 9, 2023
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born PretermThomas R Sullivan, Jacqueline F Gould, Jana M Bednarz, et al.
The Journal of Pediatrics|June 28, 2025
Implementation Fidelity of a Smartphone Application for Population-Based General Movement Assessment: The Early Moves StudyCaroline F Alexander, Sarah E Hall, Alison Salt, et al.
BMJ Open|April 10, 2021
Early Moves: a protocol for a population-based prospective cohort study to establish general movements as an early biomarker of cognitive impairment in infantsCatherine Elliott, Caroline Alexander, Alison Salt, et al.
BMJ Open|May 6, 2021
Protocol for assessing if behavioural functioning of infants born <29 weeks' gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trialJacqueline F Gould, Rachel M Roberts, Peter J Anderson, et al.
JAMA Pediatrics|November 20, 2023
High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical TrialJacqueline F Gould, Rachel M Roberts, Peter J Anderson, et al.
Pediatric Research|June 5, 2026
Blood fatty acid changes in preterm infants in a trial of enteral DHA supplementationRobert A Gibson, Maria Makrides, Jana M Bednarz, et al.
The American Journal of Clinical Nutrition|August 3, 2025
ω-3 and ω-6 fatty acid status within a week of birth in a cross-sectional study of very preterm infantsRobert A Gibson, Jana M Bednarz, Thomas R Sullivan, et al.
Pageof 4